Exploring ADR in global patent licensing (FRAND) disputes
University of Geneva expert notes ADR can play a key role
International Organization for Mediation (IOMed) hosted the “IOMed Global Series” Lecture at its Headquarters in Hong Kong today. Under the theme “Solving Global Patent Licensing FRAND Disputes: Is ADR (Mediation and Arbitration) Becoming the Standard?“, the lecture examined the growing role of mediation and arbitration in resolving global patent licensing disputes involving standard-essential patents (SEPs) licensed on fair, reasonable, and non-discriminatory (FRAND) terms. The lecture featured Prof. Jacques de Werra, Professor of Contract Law and Intellectual Property Law at the Faculty of Law of the University of Geneva, Switzerland, Founder of the Digital Law Center and member of the board of the Geneva Master in International Dispute Settlement (MIDS), as the speaker.
Prof. Jacques de Werra assessed, against recent European developments, whether alternative dispute resolution (ADR) offers a more effective framework than national court litigation for setting global FRAND terms. Prof. Jacques de Werra said, “Instead of litigating in a decentralized manner and a country-by-country fragmented manner from a geographic perspective, you can have one single dispute resolution provider, one tribunal, whose jurisdiction would be global, and the decision rendered will be enforceable almost on a worldwide basis.”
The lecture also considered specialized FRAND ADR rules, notably the emerging rules of the Patent Mediation and Arbitration Centre (PMAC) under the Agreement on a Unified Patent Court, and whether ADR models can help resolve other cross-border technology disputes. He noted, “ADR principles for FRAND disputes can potentially be standardized, and hopefully at the global level.”
This lecture has played a positive role in promoting the long-term development of international mediation. The event not only provided a valuable opportunity for dialogue within the global legal community, but also demonstrated IOMed’s professional commitment to handling cutting-edge cross-border commercial and technological disputes. Looking ahead, IOMed will continue to leverage its advantage as an international platform, deepening cooperation with member States and international organizations to jointly explore diversified pathways for peaceful dispute resolution, thereby benefiting global economic, trade, and technological innovation development.

Prof. Jacques de Werra, Professor of University of Geneva, Switzerland, speaking at IOMed Global Series Lecture
